India is Country of Origin for Rybix, CBP Says
CBP issued a final determination of the country of origin of Rybix (tramadol hydrochloride) tablets, it said in a Federal Register notice scheduled for Jan. 11, deciding that India is the country of origin for purposes of U.S. government procurement.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
CBP concluded that tramadol hydrochloride from India, blended with excipients and packaged into dosage form in France, was not substantially transformed in France, so India is the country of origin of the finished Rybix, a pharmaceutical product used for the management of moderate to moderately severe pain in adults.
Parties have until Feb. 11 to seek judicial review of this final determination, it said. Further information: Karen Greene, 202-325-0041.